TITLE

Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients

AUTHOR(S)
Jenkins, C.A.; Bruera, E.
PUB. DATE
May 1999
SOURCE
Palliative Medicine;1999, Vol. 13 Issue 3, p183
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The role of nonsteroidal anti-inflammatory drugs (NSAIDs) is examined in the control of cancer pain with a particular focus on their use as adjuvants to opioids in advanced cancer pain. These agents have both a peripheral effect on inflammation and a role in attenuating central pain pathways. The possibility of obtaining the benefits of NSAIDs with fewer side-effects by using COX-2-specific agents is discussed. The gastrointestinal, renal, haemostatic, cognitive and hypersensitivity side-effects of NSAIDs are reviewed and their potential impact assessed. The evidence for the efficacy of NSAIDs as single agents for cancer pain is reviewed together with the nine papers which have reported the effects of NSAIDs as adjuvants to opioids in cancer pain. All of these papers reported positive results of NSAIDs, but, in the absence of any randomized, double-blind controlled trials, where NSAIDs were used as adjuvants on a long-term basis alongside optimal opioid use, definite conclusions cannot be reached. Guidelines for the safe use of NSAIDs are suggested. Finally, suggestions for future research are made.
ACCESSION #
2003557

 

Related Articles

  • Management of cancer pain: ESMO Clinical Practice Guidelines. Jost, L.; Roila, F. // Annals of Oncology;May2010, Vol. 21 Issue suppl_5, pv257 

    The article focuses on the guidelines of the European Society for Medical Oncology (ESMO) for managing cancer pain. It says that analgesic therapy for cancer pain must follow the World Health Organization's (WHO) pain ladder including non-opioid analgesics or non-steroidal inflammatory drugs...

  • Lumiracoxib537. Feret, Brett // Formulary;Sep2003, Vol. 38 Issue 9, p529 

    Reports on the marketing of non-steroidal anti-inflammatory drug lumiracoxib in the U.S. Treatment of arthritis and acute pain; Efficacy of the drug for treatment of osteoarthritis; Comparison of adverse effects to other COX-2 inhibitors. INSETS: Abstract;Formulary considerations.

  • Did you know... Morrow, Shelly // Arthritis Today;Sep/Oct95, Vol. 9 Issue 5, p12 

    Presents information on the worth of nonsteroidal anti-inflammatory drugs sold in 1994.

  • NSAIDs.  // Mayo Clinic Health Letter;Dec1997, Vol. 15 Issue 12, p4 

    Focuses on nonsteriodal anti-inflammatory drug. Information on popular medications; Indepth look at the harmfulness of the drug; Details on these drugs work.

  • Safe use of NSAIDs. Rubin, Aaron; Loosli, Al // Physician & Sportsmedicine;May97, Vol. 25 Issue 5, p120p 

    Presents an abstract of the study titled `NSAIDs revisited: Selection, monitoring, and safe use,' by P. Amadio Jr., D.M. Commings et al, published in a 1997 issue of `Postgraduate Medicine.'

  • Sidestepping side effects.  // Joe Weider's Muscle & Fitness;Mar95, Vol. 56 Issue 3, p35 

    Presents nonsteroidal anti-inflammatory drugs (NSAID) as treatment for sore muscles and other post training pains. Side effects of Aspirin; Ibuprofen and naproxen over-the-counter drugs' risks for ulcers and gastrointestinal bleeding.

  • Non-steroidal anti-inflammatory drugs: Is the balance shiftong? Somerville, Kevin; Noble, George // Age & Ageing;Nov97, Vol. 26 Issue 6, p417 

    Focuses on non-steroidal ant-inflammatory drugs (NSAIDs) which have been subject to repeated warnings about their adverse drug reaction profile. Views of NSAIDs which can be bad for patients; Indepth look at adverse effects of NSAIDs; Emphasis on the upper gastrointestinal tract.

  • The role of nonsteroidal anti-inflammatory drugs in the treatment of acute soft tissue injuries. Hertel, Jay // Journal of Athletic Training (National Athletic Trainers' Associ;Oct-Dec97, Vol. 32 Issue 4, p350 

    Presents a study on the role of Nonsteroidal anti-inflammatory drugs (NSAIDs) which are used in the treatment of acute soft tissue injuries. Methodology used in the study; Conclusions reached; Recommendations of the study.

  • New NSAID strength.  // Modern Medicine;Jan94, Vol. 62 Issue 1, p37 

    Presents the tablet form of etodolac, a nonsteroidal anti-inflammatory agent from Wyeth-Ayerst Laboratories. Indications for treating signs and symptoms of osteoarthritis.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics